Spots Global Cancer Trial Database for preoperative chemotherapy
Every month we try and update this database with for preoperative chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | NCT00132639 | Pulmonary Neopl... | Preoperative do... Preoperative do... | 20 Years - 74 Years | Japan Clinical Oncology Group | |
| Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor | NCT02969122 | Stomach Neoplas... | standard gastre... hyperthermic in... Extensive intra... Preoperative ch... Postoperative c... | - | Peking University | |
| Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer | NCT04248998 | Triple-negative... | Fasting-mimicki... Metformin Preoperative ch... | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor | NCT02969122 | Stomach Neoplas... | standard gastre... hyperthermic in... Extensive intra... Preoperative ch... Postoperative c... | - | Peking University | |
| Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC | NCT00960297 | Non-Small Cell ... | Carboplatin Paclitaxel Bevacizumab | 18 Years - | SCRI Development Innovations, LLC | |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
| Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer | NCT03579004 | Esophageal Neop... Squamous Cell C... Concurrent Chem... | Paclitaxel Cisplatin Fluorouracil chemoradiothera... Ivor Lewis esop... | 18 Years - 75 Years | Russian Academy of Medical Sciences | |
| Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma. | NCT03773367 | Resectable Gast... | Fluorouracil Oxaliplatin Irinotecan | 18 Years - | Lund University Hospital | |
| Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | NCT00132639 | Pulmonary Neopl... | Preoperative do... Preoperative do... | 20 Years - 74 Years | Japan Clinical Oncology Group | |
| The PET- Retroperitoneal Sarcoma Study | NCT04224948 | Retroperitoneal... | PET MRI scan | 18 Years - | University Health Network, Toronto | |
| Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma | NCT03822936 | Cancer of Pancr... Pancreas Adenoc... Resectable Panc... | Preoperative ch... Preoperative ra... | 18 Years - 75 Years | CNAO National Center of Oncological Hadrontherapy | |
| Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | NCT00766636 | Pancreatic Canc... | Gemcitabine Radiation Thera... Erlotinib Surgery | 18 Years - | M.D. Anderson Cancer Center | |
| Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC | NCT03366883 | Esophageal Canc... Esophageal Canc... | Paclitaxel, Cis... radiochemothera... | 20 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Radiation Therapy for ypN0 Breast Cancer | NCT04240548 | Breast Cancer | Regional Nodal ... | 18 Years - 70 Years | National Cancer Institute, Egypt | |
| Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | NCT04031677 | Retroperitoneal... Liposarcoma Leiomyosarcoma | Surgery Preoperative ch... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | NCT00766636 | Pancreatic Canc... | Gemcitabine Radiation Thera... Erlotinib Surgery | 18 Years - | M.D. Anderson Cancer Center | |
| Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC | NCT00960297 | Non-Small Cell ... | Carboplatin Paclitaxel Bevacizumab | 18 Years - | SCRI Development Innovations, LLC | |
| Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer | NCT03579004 | Esophageal Neop... Squamous Cell C... Concurrent Chem... | Paclitaxel Cisplatin Fluorouracil chemoradiothera... Ivor Lewis esop... | 18 Years - 75 Years | Russian Academy of Medical Sciences | |
| Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma. | NCT03773367 | Resectable Gast... | Fluorouracil Oxaliplatin Irinotecan | 18 Years - | Lund University Hospital | |
| Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer | NCT04248998 | Triple-negative... | Fasting-mimicki... Metformin Preoperative ch... | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | NCT00132639 | Pulmonary Neopl... | Preoperative do... Preoperative do... | 20 Years - 74 Years | Japan Clinical Oncology Group | |
| Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC) | NCT05896787 | Esophageal Squa... | AK104, nab-pacl... | 18 Years - 70 Years | The First Affiliated Hospital of Zhengzhou University | |
| Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC) | NCT05896787 | Esophageal Squa... | AK104, nab-pacl... | 18 Years - 70 Years | The First Affiliated Hospital of Zhengzhou University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
